Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Resectable NSCLC × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1790 Neoplasms 1514 Carcinoma, Non-Small-Cell Lung 1046 Prostatic Neoplasms 955 Colorectal Neoplasms 882 Lung Neoplasms 812 Pancreatic Neoplasms 576 Carcinoma, Hepatocellular 544 Leukemia, Myeloid, Acute 534 Stomach Neoplasms 510 Ovarian Neoplasms 504 Neoplasm Metastasis 491 Multiple Myeloma 482 Recurrence 408 Melanoma 387 Uterine Cervical Neoplasms 371 Squamous Cell Carcinoma of Head and Neck 363 Head and Neck Neoplasms 357 Brain Neoplasms 353 Esophageal Neoplasms 323 Precursor Cell Lymphoblastic Leukemia-Lymphoma 314 Lymphoma 310 Endometrial Neoplasms 308 Triple Negative Breast Neoplasms 294 Glioblastoma 288 Rectal Neoplasms 285 Sarcoma 270 Urinary Bladder Neoplasms 268 Hematologic Neoplasms 262 Colonic Neoplasms 261

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07492342 2026-03-25

K-NADIR

The First Affiliated Hospital of Guangzhou Medical University

Phase 2 Recruiting

Resectable NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡